ANDREW FRUHSCHIEN: Open Payments
NPI 1841575552 · MAHWAH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 14 payments from 5 companies in 2025. Trend: 2023 $75 · 2024 $286 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 1 | $181 |
| Amgen Inc. | 7 | $181 |
| Actelion Pharmaceuticals US, Inc. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| PFIZER INC. | 1 | $18 |
Products named: Cleerly Ischemia, Repatha, FARXIGA, OPSUMIT, VYNDAQEL, OPSYNVI.
Industry payments across NJ — which companies pay providers there.
